Wellmarker Bio(WMBIO), a Korean biomarker-based anti-cancer drug development company, said it has signed an MOU with a Ukrainian top national medical institutions, the Vinnytsya National Medical University(VNMU) named after M.Pirogov and the Podilskyi Regional Center of Oncology(PRCO) on March 4th, 2019 to build strong research collaboration and establish non-clinical center in Ukraine.